MA25433A1 - Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux - Google Patents

Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux

Info

Publication number
MA25433A1
MA25433A1 MA26547A MA26547A MA25433A1 MA 25433 A1 MA25433 A1 MA 25433A1 MA 26547 A MA26547 A MA 26547A MA 26547 A MA26547 A MA 26547A MA 25433 A1 MA25433 A1 MA 25433A1
Authority
MA
Morocco
Prior art keywords
arylmethyl
carbonylamino
preparation
antitumor agents
thiazole derivatives
Prior art date
Application number
MA26547A
Other languages
English (en)
Inventor
Paolo Pevarello
Manuela Villa
Barbara Salom
Mario Varasi
Raffaella Amici
Anna Vulpetti
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of MA25433A1 publication Critical patent/MA25433A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Psychiatry (AREA)
  • Pulmonology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
MA26547A 1999-08-12 2002-03-11 Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux MA25433A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/372,832 US6114365A (en) 1999-08-12 1999-08-12 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents

Publications (1)

Publication Number Publication Date
MA25433A1 true MA25433A1 (fr) 2002-04-01

Family

ID=23469806

Family Applications (1)

Application Number Title Priority Date Filing Date
MA26547A MA25433A1 (fr) 1999-08-12 2002-03-11 Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux

Country Status (36)

Country Link
US (3) US6114365A (fr)
EP (1) EP1204649B1 (fr)
JP (1) JP4864260B2 (fr)
KR (2) KR100773709B1 (fr)
CN (1) CN100410245C (fr)
AP (1) AP1853A (fr)
AT (1) ATE375987T1 (fr)
AU (1) AU782882B2 (fr)
BG (1) BG65484B1 (fr)
BR (1) BR0013281A (fr)
CA (1) CA2381097C (fr)
CY (1) CY1107108T1 (fr)
CZ (1) CZ303138B6 (fr)
DE (1) DE60036803T2 (fr)
DK (1) DK1204649T3 (fr)
EA (1) EA005375B1 (fr)
EE (1) EE04939B1 (fr)
ES (1) ES2295056T3 (fr)
GE (1) GEP20053475B (fr)
HK (1) HK1054233B (fr)
HR (1) HRP20020127B1 (fr)
HU (1) HUP0202492A3 (fr)
IL (2) IL147924A0 (fr)
IS (1) IS2594B (fr)
MA (1) MA25433A1 (fr)
MX (1) MXPA02001508A (fr)
NO (1) NO323576B1 (fr)
NZ (1) NZ517236A (fr)
OA (1) OA12047A (fr)
PT (1) PT1204649E (fr)
RS (1) RS50300B (fr)
SI (1) SI1204649T1 (fr)
SK (1) SK287373B6 (fr)
UA (1) UA72538C2 (fr)
WO (1) WO2001014353A1 (fr)
ZA (1) ZA200201117B (fr)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020150921A1 (en) * 1996-02-09 2002-10-17 Francis Barany Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
US6407103B2 (en) 1998-04-21 2002-06-18 Bristol-Myers Squibb Pharma Company Indeno [1,2-c] pyrazol-4-ones and their uses
US6320050B1 (en) * 1999-03-29 2001-11-20 Hoffmann-La Roche Inc. Heteroaromatic glucokinase activators
US6610846B1 (en) * 1999-03-29 2003-08-26 Hoffman-La Roche Inc. Heteroaromatic glucokinase activators
EP3222619A1 (fr) 1999-04-15 2017-09-27 Bristol-Myers Squibb Holdings Ireland Inhibiteurs cycliques de la protéine tyrosine kinase
US7125875B2 (en) * 1999-04-15 2006-10-24 Bristol-Myers Squibb Company Cyclic protein tyrosine kinase inhibitors
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
AU775373B2 (en) 1999-10-01 2004-07-29 Immunogen, Inc. Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
US6291504B1 (en) 1999-10-20 2001-09-18 Dupont Pharmaceuticals Company Acylsemicarbazides and their uses
US20040048844A1 (en) * 1999-10-20 2004-03-11 Bristol-Myers Squibb Pharma Company Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents
WO2002048114A1 (fr) * 2000-11-27 2002-06-20 Pharmacia Italia S.P.A. Derives phenylacetamido-pyrazole et leur utilisation comme agents antitumoraux
WO2002044174A2 (fr) * 2000-12-01 2002-06-06 Bristol-Myers Squibb Pharma Company Derives de 3-(2,4-dimethylthiazol-5-yl)indeno[1,2-c]pyrazol-4-one et leur utilisation
AU2002228849A1 (en) 2000-12-08 2002-06-18 Bristol-Myers Squibb Pharma Company Semicarbazides and their uses as cyclin dependent kinase inhibitors
WO2002050071A1 (fr) * 2000-12-21 2002-06-27 Bristol-Myers Squibb Company Inhibiteurs thiazolyl des tyrosine kinases de la famille tec
ES2254611T3 (es) * 2001-05-11 2006-06-16 Pfizer Products Inc. Derivados de tiazol.
EP1724270A3 (fr) 2001-07-19 2007-01-03 Pfizer Italia S.r.l. Dérivés de phenylacetamido-thiazole, leur procédé de préparation et leur utilisation en tant qu'agents antitumoraux
DE60216097T2 (de) * 2001-07-19 2007-06-28 Pfizer Italia S.R.L. Phenylacetamido-thiazole verbindungen, verfahren zu ihren herstellung und ihre anwendung als antitumor mittel
WO2003027104A1 (fr) * 2001-09-27 2003-04-03 Idrtech Inc. Derives de fumagillol et procede permettant de les preparer
KR101018318B1 (ko) * 2001-12-21 2011-03-04 노보 노르디스크 에이/에스 Ｇｋ 활성제로서의 아미드 유도체
MXPA05000130A (es) * 2002-06-27 2005-02-17 Novo Nordisk As Derivados de aril-carbonilo como agentes terapeuticos.
JP2006517577A (ja) * 2003-02-12 2006-07-27 ファイザー・インク 抗増殖性の２−（スルホ−フェニル）−アミノチアゾール誘導体
EP1597256A1 (fr) * 2003-02-21 2005-11-23 Pfizer Inc. Derives d'amino-thiazole substitues par n-heterocyclyle en tant qu'inhibiteurs de la proteine kinase
WO2004087138A1 (fr) * 2003-03-31 2004-10-14 Sucampo Ag Procede de traitement de maladie vasculaire hyperpermeable
WO2005014591A1 (fr) * 2003-07-15 2005-02-17 L'oreal 2-acylamino ou 2-sulfonylamino-1, 3-thiazoles en tant qu'agents de couplage pour la coloration d'oxydation de fibres keratiniques
FR2857664B1 (fr) * 2003-07-15 2007-12-14 Oreal Nouveaux derives thiazoles et utilisation de ces derives pour la teinture des fibres keratiniques
US7351727B2 (en) * 2003-09-02 2008-04-01 Bristol-Myers Squibb Company Inhibitors of 15-lipoxygenase
US20050074424A1 (en) * 2003-10-03 2005-04-07 Lev Salnikov Using polyion polymers with glucose infusion for a cancer selective chemotherapy compound and method
US20070196395A1 (en) * 2003-12-12 2007-08-23 Mackerell Alexander Immunomodulatory compounds that target and inhibit the py'binding site of tyrosene kinase p56 lck sh2 domain
CN102516240A (zh) * 2004-01-06 2012-06-27 诺和诺德公司 杂芳基脲及其作为葡糖激酶活化剂的用途
WO2006002119A2 (fr) 2004-06-18 2006-01-05 Gpc Biotech, Inc. Utilisation d'inhibiteurs de kinase et leurs compositions
EP1621539A1 (fr) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Dérivées d'urée cyclique substitués par un heterocycle, leur prépration et leur utilisation pharmaceutique comee inhibiteurs de kinases
EP1621536A1 (fr) * 2004-07-27 2006-02-01 Aventis Pharma S.A. Dérivés d'urées cycliques aminés, leur préparation et utilisation pharmaceutique en tant qu'inhibiteurs de Kinase
CA2575466A1 (fr) * 2004-08-13 2006-02-23 Genentech, Inc. Composes a base de 2-amido-thiazole presentant une activite inhibitrice enzymatique utilisant de l'adenosine triphosphate (atp), et compositions, et leurs utilisations
EP2096107A1 (fr) 2004-12-23 2009-09-02 GPC Biotech AG Dérivés d'acide squarique dotés d'une activité anti-proliférante
AU2006343359A1 (en) * 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
US7999114B2 (en) * 2005-07-08 2011-08-16 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
CA2615938C (fr) 2005-07-14 2014-04-29 Novo-Nordisk A/S Activateurs de l'uree glucokinase
EP1914234A1 (fr) * 2006-10-16 2008-04-23 GPC Biotech Inc. Pyrido[2,3-d]pyrimidines et leur utilisation comme inhibiteurs de kinases
WO2008084043A1 (fr) * 2007-01-09 2008-07-17 Novo Nordisk A/S Activateurs de la glucokinase à base d'urée
WO2008084044A1 (fr) 2007-01-11 2008-07-17 Novo Nordisk A/S Activateurs de l'urée glucokinase
US8153792B2 (en) * 2007-02-13 2012-04-10 Ab Science Process for the synthesis of 2-aminothiazole compounds as kinase inhibitors
US8450348B2 (en) * 2007-02-21 2013-05-28 Forma Tm, Llc Derivatives of squaric acid with anti-proliferative activity
TWI437986B (zh) * 2008-01-31 2014-05-21 R Tech Ueno Ltd 噻唑衍生物及使用該衍生物作為ｖａｐ－１抑制劑之用途
US8232402B2 (en) 2008-03-12 2012-07-31 Link Medicine Corporation Quinolinone farnesyl transferase inhibitors for the treatment of synucleinopathies and other indications
EP2112152A1 (fr) 2008-04-22 2009-10-28 GPC Biotech AG Dihydropteridinones comme inhibiteurs Plk
EP2112150B1 (fr) 2008-04-22 2013-10-16 Forma Therapeutics, Inc. Inhibiteurs Raf améliorés
JP2012508768A (ja) 2008-11-13 2012-04-12 リンク・メディスン・コーポレーション アザキノリノン誘導体及びその使用
UA103918C2 (en) * 2009-03-02 2013-12-10 Айерем Элелси N-(hetero)aryl, 2-(hetero)aryl-substituted acetamides for use as wnt signaling modulators
AR075899A1 (es) * 2009-03-20 2011-05-04 Onyx Therapeutics Inc Tripeptidos epoxicetonas cristalinos inhibidores de proteasa
EP2440556A1 (fr) * 2009-06-10 2012-04-18 Vertex Pharmaceuticals Incorporated Inhibiteurs de la phosphatidylinositol 3-kinase
DE102009043260A1 (de) * 2009-09-28 2011-04-28 Merck Patent Gmbh Pyridinyl-imidazolonderivate
EP2325185A1 (fr) 2009-10-28 2011-05-25 GPC Biotech AG Inhibiteur de Plk
HU0900798D0 (en) 2009-12-21 2010-03-01 Vichem Chemie Kutato Kft 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
WO2012092471A2 (fr) * 2010-12-29 2012-07-05 Development Center For Biotechnology Nouveaux inhibiteurs de tubuline et procédés pour les utiliser
RU2011122942A (ru) 2011-06-08 2012-12-20 Общество С Ограниченной Ответственностью "Асинэкс Медхим" Новые ингибиторы киназ
CN103387551B (zh) * 2012-05-11 2015-05-20 中国人民解放军军事医学科学院毒物药物研究所 噻唑类化合物及其用途
SG10201701438QA (en) 2012-08-23 2017-03-30 Virostatics Srl Novel 4,6-disubstituted aminopyrimidine derivatives
MX2018012287A (es) 2016-04-11 2019-02-07 Genfit Metodos de tratamiento para enfermedades colestasicas y fibroticas.
KR20200104873A (ko) 2017-12-06 2020-09-04 린 바이오사이언스, 피티와이 엘티디. 튜불린 억제제
CN111741944A (zh) * 2018-02-01 2020-10-02 悉尼大学 抗癌化合物
MX2020008905A (es) 2018-06-12 2020-12-03 Vtv Therapeutics Llc Usos terapeuticos de activadores de glucoquinasa en combinacion con insulina o analogos de insulinas.
EP3712127A1 (fr) 2019-03-22 2020-09-23 Deutsches Krebsforschungszentrum Nouveaux inhibiteurs de l'histone déacétylase 10
WO2020193431A1 (fr) 2019-03-22 2020-10-01 Deutsches Krebsforschungszentrum Nouveaux inhibiteurs de l'histone désacétylase 10
EP4104835A4 (fr) * 2020-02-10 2024-05-01 Juntendo Educational Foundation Inhibiteur de l'activité du récepteur de la ryanodine de type 2
CN115322208B (zh) * 2021-05-10 2023-04-11 中国药科大学 2-氨基噻唑类衍生物及其制备方法和医药用途
WO2023182780A1 (fr) * 2022-03-22 2023-09-28 오토텔릭바이오 주식회사 Composé dérivé de thiazole et ses utilisations

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL125062C (fr) * 1960-04-20
TW513418B (en) * 1996-07-31 2002-12-11 Otsuka Pharma Co Ltd Thiazole derivatives, their production and use
JPH1095777A (ja) * 1996-07-31 1998-04-14 Otsuka Pharmaceut Co Ltd チアゾール誘導体
US6794392B1 (en) * 1996-09-30 2004-09-21 Schering Aktiengesellschaft Cell differentiation inducer
HUP0004512A3 (en) * 1997-10-27 2003-01-28 Agouron Pharmaceuticals Inc La 4-aminothiazole derivatives, their preparation and their use as inhibitors of cyclin-dependent kinases
US6040321A (en) * 1997-11-12 2000-03-21 Bristol-Myers Squibb Company Aminothiazole inhibitors of cyclin dependent kinases
ATE288904T1 (de) * 1998-06-18 2005-02-15 Bristol Myers Squibb Co Durch kohlenstoff substituierte aminothiazole als inhibitoren von zyclin-abhägigen kinasen
GB9823871D0 (en) * 1998-10-30 1998-12-23 Pharmacia & Upjohn Spa 2-Amino-thiazole derivatives, process for their preparation, and their use as antitumour agents
EP3222619A1 (fr) * 1999-04-15 2017-09-27 Bristol-Myers Squibb Holdings Ireland Inhibiteurs cycliques de la protéine tyrosine kinase
US6114365A (en) 1999-08-12 2000-09-05 Pharmacia & Upjohn S.P.A. Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents
US6992081B2 (en) * 2000-03-23 2006-01-31 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
SE0102440D0 (sv) * 2001-07-05 2001-07-05 Astrazeneca Ab New compound
EP1321463B1 (fr) * 2001-12-21 2007-08-08 Virochem Pharma Inc. Dérivés de thiazole et leur utilisation dans le traitement ou la prévention d'infections par des Flavivirus
KR101154163B1 (ko) * 2003-01-27 2012-06-14 아스텔라스세이야쿠 가부시키가이샤 티아졸 유도체 및 ｖａｐ-1 저해제로서의 용도

Also Published As

Publication number Publication date
OA12047A (en) 2006-05-02
AP2002002441A0 (en) 2002-03-31
JP2003507461A (ja) 2003-02-25
HK1054233A1 (en) 2003-11-21
MXPA02001508A (es) 2003-07-21
YU9702A (sh) 2004-11-25
HRP20020127B1 (en) 2010-08-31
ES2295056T3 (es) 2008-04-16
CA2381097C (fr) 2009-06-16
EP1204649B1 (fr) 2007-10-17
CZ2002486A3 (cs) 2002-11-13
DK1204649T3 (da) 2007-12-03
PL353588A1 (en) 2003-12-01
CN1425009A (zh) 2003-06-18
ZA200201117B (en) 2003-04-30
PT1204649E (pt) 2008-01-10
HUP0202492A2 (hu) 2002-11-28
DE60036803D1 (de) 2007-11-29
AP1853A (en) 2008-05-29
CA2381097A1 (fr) 2001-03-01
NO323576B1 (no) 2007-06-11
DE60036803T2 (de) 2008-07-24
UA72538C2 (en) 2005-03-15
ATE375987T1 (de) 2007-11-15
US20050004120A1 (en) 2005-01-06
NZ517236A (en) 2004-11-26
KR100827563B1 (ko) 2008-05-07
CY1107108T1 (el) 2012-10-24
JP4864260B2 (ja) 2012-02-01
SK287373B6 (sk) 2010-08-09
IL147924A (en) 2008-03-20
IS6264A (is) 2002-02-11
EP1204649A1 (fr) 2002-05-15
IL147924A0 (en) 2002-08-14
HK1054233B (zh) 2009-05-29
BG65484B1 (bg) 2008-09-30
BG106481A (en) 2002-09-30
CN100410245C (zh) 2008-08-13
CZ303138B6 (cs) 2012-04-25
RS50300B (sr) 2009-09-08
EA005375B1 (ru) 2005-02-24
EE04939B1 (et) 2007-12-17
GEP20053475B (en) 2005-03-25
AU7440000A (en) 2001-03-19
HRP20020127A2 (en) 2003-04-30
NO20020683D0 (no) 2002-02-11
BR0013281A (pt) 2002-06-18
SI1204649T1 (sl) 2008-02-29
US6784198B1 (en) 2004-08-31
EE200200064A (et) 2003-04-15
SK1802002A3 (en) 2003-05-02
AU782882B2 (en) 2005-09-08
KR20020060159A (ko) 2002-07-16
IS2594B (is) 2010-03-15
KR100773709B1 (ko) 2007-11-09
EA200200247A1 (ru) 2002-08-29
HUP0202492A3 (en) 2004-12-28
WO2001014353A1 (fr) 2001-03-01
US6114365A (en) 2000-09-05
KR20070074003A (ko) 2007-07-10
NO20020683L (no) 2002-04-10

Similar Documents

Publication Publication Date Title
MA25433A1 (fr) Derives d'arylmethyl-carbonylamino-thiazole, leur procede de preparation et leur utilisation en tant qu'agents antitumoraux
MA25493A1 (fr) Derives de 3(5)-amino-pyrazole, procede pour leur preparation et leur utilisation en tant qu'agents antitumoraux.
GB9911053D0 (en) 4,5,6,7-tetrahydroindazole derivatives process for their preparation and their use as antitumour agents
GB9823873D0 (en) 2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
IL147925A0 (en) 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
EE200100252A (et) Pürimidiinderivaadid, nende valmistamismeetod ja kasutamine, farmatseutiline kompositsioon ja sellevalmistamismeetod, kombinatsioon ning saadus
EE200100431A (et) 16-halogenoepotilooni derivaadid, nende valmistamismeetod ja farmatseutiline kasutamine
MA26831A1 (fr) Derives de benzodiazepine."
EE200200095A (et) Sulfonüülkarboksamiidi derivaadid, nende kasutamine, ravim ja nende valmistamismeetod
MA25223A1 (fr) Procede pour la preparation de 4-carboxy-amino-2-substitue-1,2,3,4 tetrahydroquinoleine
FR13C0008I2 (fr) Derives de phosphonocephem, leur procede de preparation et leur utilisation
HUP0202832A3 (en) New pyrimidine-2,4,6-trione derivatives, processes for their production and pharmaceutical agents containing these compounds
MA25867A1 (fr) Procede pour la preparation de derives de pyrazolo [4,3-d] pyrimidine-7-one-3-pyridylsulfonyle, et intermediaires utilises
FR2778917B1 (fr) Nouveaux derives d'histidine, procede de preparation et utilisations
FR2827864B1 (fr) Nouveaux derives de benzo[b]pyrano[3,2-h]acridin-7-one, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
FR2796963B1 (fr) Procede d'obtention de lignees isotransgeniques
FR2780967B1 (fr) Procede de preparation de derives du 2,3-dihydrobenzofurane -2,2-disubstitues
FR2797443B1 (fr) Procede de prepartion de quinoleine-5,8-diones
FR2808274B1 (fr) Procede de preparation des n, n'-carbonylbislactames
DZ3260A1 (fr) PROCEDE DE PREPARATION DE 1,4]DIAZEPINO 6,7,1- i hi /i ]INDOL-4-ONES SUBSTITUEES
FR2789990B1 (fr) Procede de preparation de derives d'aminobenzophenones
FR2792637B1 (fr) Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
MA25828A1 (fr) Procede de preparation d'oligomeres de galactomannanes
FR2775973B1 (fr) Nouveaux derives d'histidine, procede de preparation et utilisations
FR2820135B1 (fr) Derives d'acyclonucleosides pyrimidiniques, leur procede de preparation et leur utilisation